How much does a box of dabrafenib cost?

Dabrafenib is a drug that targets certain types of cancer. It belongs to the BRAF inhibitor drug class and is used to treat two types of cancer: malignant melanoma and avesicular thyroid cancer.

Dabrafenib is now on the market in China and has been successfully included in medical insurance. Patients can purchase the drug domestically. However, its price is relatively high, about more than 10,000 yuan, which is still a considerable burden for many patients. Specific prices may vary depending on region and hospital pharmacy, and patients are advised to consult their local hospital pharmacy for the most accurate price information.

In comparison, the price of foreign generic drugs of dabrafenib is relatively affordable, especially the generic drugs in Laos, which cost around two to three thousand yuan, which is much cheaper than the domestic original drug. Although it is a generic drug, its drug ingredients are basically the same as those of domestic original drugs, so patients can consider purchasing foreign generic drugs to reduce financial pressure. However, when purchasing foreign drugs, patients need to pay attention to the source and quality of the drugs and ensure that they purchase drugs from formal channels.

In malignant melanoma, the V600 mutation of the BRAF gene is found in approximately half of patients. This mutation causes abnormal activity of BRAF kinase, which promotes the growth and spread of cancer cells. The mechanism of action of dabrafenib is to inhibit the proliferation and metastasis of cancer cells by inhibiting the activity of BRAF kinase. Therefore, dabrafenib is approved for the treatment of advanced or metastatic malignant melanoma with BRAF V600 mutations.

In addition, dabrafenib is also used to treat BRAF V600E mutated avesicular thyroid cancer. Similar to malignant melanoma, this mutation also triggers abnormal activity of BRAF kinase, promoting the growth and spread of cancer cells. Dabrafenib works by inhibiting the activity of this abnormal kinase, thereby inhibiting the growth and spread of cancer cells.

xa0